AML: high serum ferritin at initial diagnosis has a negative impact on long-term survival

Leukemia & Lymphoma
Jana IhlowJörg Westermann

Abstract

Increased serum ferritin (SF) is common in hematologic malignancies; however, its prognostic role in acute myeloid leukemia (AML) is not clearly established. We examined the impact of baseline SF on long-term survival in 137 intensively treated AML patients. Patients and baseline characteristics were retrieved from an AML database at Charité University Medical Center Berlin, Campus Virchow Clinic. After c-reactive protein (CRP)-based adjustment for inflammation, patients were grouped according to their baseline SF level. Survival analysis was performed accordingly. A significant decline in overall survival and relapse-free survival was observed in patients with high SF as compared to those with low SF. Furthermore, elevated baseline SF remained an independent poor prognostic factor within the multivariate analysis and was associated with a significant higher risk of relapse and non-relapse mortality (NRM). In conclusion, our data show that elevated baseline SF has a negative impact on long-term survival in intensively treated AML patients.

References

May 1, 1977·British Journal of Cancer·S J CraggM Worwood
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·H E BroxmeyerP Arosio
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Dec 23, 1999·The New England Journal of Medicine·N C Andrews
Oct 20, 2001·Best Practice & Research. Clinical Haematology·D Grimwade
Apr 13, 2004·European Journal of Gastroenterology & Hepatology·Gwo-Tzer HoAdrian J Stanley
Feb 4, 2006·Blood·Frederick R AppelbaumStephen H Petersdorf
Nov 28, 2006·Lancet·Elihu Estey, Hartmut Döhner
Oct 22, 2008·Biochimica Et Biophysica Acta·Paolo ArosioPatrizia Cavadini
Mar 20, 2009·Leukemia·R NaughtonT G Cotter
Mar 23, 2010·Biochimica Et Biophysica Acta·Wei WangSuzy V Torti
Jan 19, 2012·International Journal of Epidemiology·Per Kragh AndersenHein Putter
Mar 13, 2012·International Journal of Hematology·Shohei KikuchiJunji Kato
Feb 13, 2013·Lancet·Felicetto Ferrara, Charles A Schiffer
May 30, 2013·Journal of Leukocyte Biology·Fuling ZhouFrançois X Claret
Feb 4, 2014·British Journal of Haematology·Ruediger LierschUtz Krug
Nov 27, 2014·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Jan 27, 2015·International Journal of Molecular Sciences·Christine RichardsonC Greer Vestal
Sep 17, 2015·The New England Journal of Medicine·Hartmut DöhnerClara D Bloomfield
Aug 23, 2017·Experimental Hematology·Alyssa H CullMichael J Rauh

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.